Effect of trifluoperazine, D600, and phenytoin on depolarization- and thyrotropin-releasing hormone-induced thyrotropin release from rat pituitary tissue.
D000818:Animals; D002118:Calcium / Q000378:metabolism; D005711:Gallopamil / Q000494:pharmacology*; D007473:Ion Channels / Q000378:metabolism; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D010672:Phenytoin / Q000494:pharmacology*; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D011188:Potassium / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology*; D014700:Verapamil / Q000031:analogs & derivatives*; D014701:Veratridine / Q000494:pharmacology
D007473:Ion Channels; D014268:Trifluoperazine; D005711:Gallopamil; D013973:Thyrotropin-Releasing Hormone; D010672:Phenytoin; D014701:Veratridine; D013972:Thyrotropin; D012964:Sodium; D014700:Verapamil; D011188:Potassium; D002118:Calcium